Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

A prophylactic multi-strain probiotic treatment to reduce the absorption of toxic elements: In-vitro study and biomonitoring of breast milk and infant stools.

Astolfi ML, Protano C, Schiavi E, Marconi E, Capobianco D, Massimi L, Ristorini M, Baldassarre ME, Laforgia N, Vitali M, Canepari S, Mastromarino P.

Environ Int. 2019 Sep;130:104818. doi: 10.1016/j.envint.2019.05.012. Epub 2019 Jul 3.

2.

Divergent Effectiveness of Multispecies Probiotic Preparations on Intestinal Microbiota Structure Depends on Metabolic Properties.

Biagioli M, Capobianco D, Carino A, Marchianò S, Fiorucci C, Ricci P, Distrutti E, Fiorucci S.

Nutrients. 2019 Feb 2;11(2). pii: E325. doi: 10.3390/nu11020325.

3.

No changes in Interleukin-10 expression in symptomatic uncomplicated diverticular disease of the colon.

Tursi A, Mastromarino P, Capobianco D, Elisei W, Picchio M, Brandimarte G.

J Gastrointestin Liver Dis. 2018 Dec;27(4):476-477. doi: 10.15403/jgld.2014.1121.274.ink. No abstract available.

4.

Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense.

Valenti P, Rosa L, Capobianco D, Lepanto MS, Schiavi E, Cutone A, Paesano R, Mastromarino P.

Front Immunol. 2018 Mar 1;9:376. doi: 10.3389/fimmu.2018.00376. eCollection 2018. Review.

5.

Effectiveness and Safety of a Probiotic-Mixture for the Treatment of Infantile Colic: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial with Fecal Real-Time PCR and NMR-Based Metabolomics Analysis.

Baldassarre ME, Di Mauro A, Tafuri S, Rizzo V, Gallone MS, Mastromarino P, Capobianco D, Laghi L, Zhu C, Capozza M, Laforgia N.

Nutrients. 2018 Feb 10;10(2). pii: E195. doi: 10.3390/nu10020195.

6.

Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing.

Trinchieri V, Laghi L, Vitali B, Parolin C, Giusti I, Capobianco D, Mastromarino P, De Simone C.

Front Immunol. 2017 Nov 6;8:1474. doi: 10.3389/fimmu.2017.01474. eCollection 2017.

7.

Urinary metabolic profiling and symptomatic uncomplicated diverticular disease of the colon.

Tursi A, Mastromarino P, Capobianco D, Elisei W, Miccheli A, Pratico' G, Picchio M, Brandimarte G.

Clin Res Hepatol Gastroenterol. 2017 Jun;41(3):344-346. doi: 10.1016/j.clinre.2017.01.006. Epub 2017 Mar 9. No abstract available.

PMID:
28286055
9.

Assessment of Fecal Microbiota and Fecal Metabolome in Symptomatic Uncomplicated Diverticular Disease of the Colon.

Tursi A, Mastromarino P, Capobianco D, Elisei W, Miccheli A, Capuani G, Tomassini A, Campagna G, Picchio M, Giorgetti G, Fabiocchi F, Brandimarte G.

J Clin Gastroenterol. 2016 Oct;50 Suppl 1:S9-S12. doi: 10.1097/MCG.0000000000000626.

PMID:
27622378
10.

Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia.

Mastromarino P, Capobianco D, Cannata F, Nardis C, Mattia E, De Leo A, Restignoli R, Francioso A, Mosca L.

Antiviral Res. 2015 Nov;123:15-21. doi: 10.1016/j.antiviral.2015.08.010. Epub 2015 Aug 19.

PMID:
26296578
11.

Administration of a multistrain probiotic product (VSL#3) to women in the perinatal period differentially affects breast milk beneficial microbiota in relation to mode of delivery.

Mastromarino P, Capobianco D, Miccheli A, Praticò G, Campagna G, Laforgia N, Capursi T, Baldassarre ME.

Pharmacol Res. 2015 May-Jun;95-96:63-70. doi: 10.1016/j.phrs.2015.03.013. Epub 2015 Mar 31.

PMID:
25836922
12.

Correlation between lactoferrin and beneficial microbiota in breast milk and infant's feces.

Mastromarino P, Capobianco D, Campagna G, Laforgia N, Drimaco P, Dileone A, Baldassarre ME.

Biometals. 2014 Oct;27(5):1077-86. doi: 10.1007/s10534-014-9762-3. Epub 2014 Jun 27.

PMID:
24970346

Supplemental Content

Loading ...
Support Center